HealthMore in Health→
Pilot treatment targeting a key preeclampsia protein shows early safety signal in very preterm pregnancies
Key Takeaways
- Pilot study tested selective removal of sFlt-1, a protein implicated in preeclampsia.
- Researchers reported stable maternal and fetal measures during treatment in the study setting.
- Multiple-dose treatment was associated with modest average reductions in sFlt-1 and mean arterial pressure.
- Larger controlled trials are needed to determine whether the approach improves pregnancy and neonatal outcomes.
DE
DT Editorial Team··via nature.com
